World News

ESMO Calls for Cancer to Remain a Flagship Priority in the...

Ogkologos - 5 Νοεμβρίου, 2025

Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer...

Ogkologos - 4 Νοεμβρίου, 2025

ESMO Award for Immuno-Oncology 2025 Recipient Announced

Ogkologos - 4 Νοεμβρίου, 2025

Trastuzumab Deruxtecan Plus Pertuzumab Reduce a Risk of Progression or Death...

Ogkologos - 3 Νοεμβρίου, 2025

FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with...

Ogkologos - 30 Οκτωβρίου, 2025

Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active...

Ogkologos - 29 Οκτωβρίου, 2025

EMA Recommends Extension of Indications for Sugemalimab

Ogkologos - 28 Οκτωβρίου, 2025

Marking Breast Cancer Awareness Month 2025, ESMO Calls for Increasing Awareness...

Ogkologos - 27 Οκτωβρίου, 2025

FDA Approves Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma

Ogkologos - 27 Οκτωβρίου, 2025

Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated...

Ogkologos - 24 Οκτωβρίου, 2025

1...343536...432 Σελίδα 35 από 432

MOST POPULAR

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

27 Μαΐου, 2022

Today is Giving Tuesday

1 Δεκεμβρίου, 2020

First targeted treatment approved for advanced prostate cancer on NHS in...

13 Οκτωβρίου, 2021

Triple negative breast cancer drug given initial ‘no’ for NHS in...

8 Απριλίου, 2022

Φόρτωση περισσοτέρων

ESMO Calls for Cancer to Remain a Flagship Priority in the...

Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer...

ESMO Award for Immuno-Oncology 2025 Recipient Announced

Trastuzumab Deruxtecan Plus Pertuzumab Reduce a Risk of Progression or Death...

FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with...

Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active...

EMA Recommends Extension of Indications for Sugemalimab

Marking Breast Cancer Awareness Month 2025, ESMO Calls for Increasing Awareness...

FDA Approves Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma

Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated...

MOST POPULAR

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

Today is Giving Tuesday

First targeted treatment approved for advanced prostate cancer on NHS in...

Triple negative breast cancer drug given initial ‘no’ for NHS in...

HOT NEWS

How to Tell If Cancer Information on Social Media Is “Fake...

Cross-Border Network of European Specialists Provides New Treatment Options For Women...

FDA Approves Amivantamab-vmjw for EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung...

Intracranial Efficacy of Pembrolizumab in Patients with Brain Metastases

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ